1. Home
  2. ISSC vs BHST Comparison

ISSC vs BHST Comparison

Compare ISSC & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISSC
  • BHST
  • Stock Information
  • Founded
  • ISSC 1988
  • BHST 2007
  • Country
  • ISSC United States
  • BHST Canada
  • Employees
  • ISSC N/A
  • BHST N/A
  • Industry
  • ISSC EDP Services
  • BHST
  • Sector
  • ISSC Technology
  • BHST
  • Exchange
  • ISSC Nasdaq
  • BHST Nasdaq
  • Market Cap
  • ISSC N/A
  • BHST 106.0M
  • IPO Year
  • ISSC 2000
  • BHST N/A
  • Fundamental
  • Price
  • ISSC $6.42
  • BHST $6.49
  • Analyst Decision
  • ISSC
  • BHST Strong Buy
  • Analyst Count
  • ISSC 0
  • BHST 2
  • Target Price
  • ISSC N/A
  • BHST $13.00
  • AVG Volume (30 Days)
  • ISSC 91.6K
  • BHST 10.2K
  • Earning Date
  • ISSC 05-12-2025
  • BHST 03-31-2025
  • Dividend Yield
  • ISSC N/A
  • BHST N/A
  • EPS Growth
  • ISSC 3.71
  • BHST N/A
  • EPS
  • ISSC 0.38
  • BHST N/A
  • Revenue
  • ISSC $53,858,686.00
  • BHST $25,188,000.00
  • Revenue This Year
  • ISSC $31.35
  • BHST $161.11
  • Revenue Next Year
  • ISSC $16.39
  • BHST $64.74
  • P/E Ratio
  • ISSC $16.57
  • BHST N/A
  • Revenue Growth
  • ISSC 43.24
  • BHST 98.77
  • 52 Week Low
  • ISSC $4.91
  • BHST $0.00
  • 52 Week High
  • ISSC $12.17
  • BHST $7.38
  • Technical
  • Relative Strength Index (RSI)
  • ISSC 35.57
  • BHST N/A
  • Support Level
  • ISSC $6.65
  • BHST N/A
  • Resistance Level
  • ISSC $6.81
  • BHST N/A
  • Average True Range (ATR)
  • ISSC 0.25
  • BHST 0.00
  • MACD
  • ISSC 0.07
  • BHST 0.00
  • Stochastic Oscillator
  • ISSC 27.72
  • BHST 0.00

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: